Published in Trends Neurosci on August 01, 2001
Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain (2009) 7.11
Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat Med (2008) 3.83
MAP kinase and pain. Brain Res Rev (2008) 3.75
Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc Natl Acad Sci U S A (2003) 3.17
Metabolomics implicates altered sphingolipids in chronic pain of neuropathic origin. Nat Chem Biol (2012) 2.76
p38 MAPK, microglial signaling, and neuropathic pain. Mol Pain (2007) 2.72
JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. J Neurosci (2009) 2.64
Neuron-glia signaling in trigeminal ganglion: implications for migraine pathology. Headache (2007) 2.36
Glia and pain: is chronic pain a gliopathy? Pain (2013) 2.21
T-cell infiltration and signaling in the adult dorsal spinal cord is a major contributor to neuropathic pain-like hypersensitivity. J Neurosci (2009) 1.91
Kinase cascades and ligand-directed signaling at the kappa opioid receptor. Psychopharmacology (Berl) (2010) 1.90
Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine. Brain Behav Immun (2006) 1.88
Mechanisms of chronic central neuropathic pain after spinal cord injury. Brain Res Rev (2008) 1.69
TNF-alpha and neuropathic pain--a review. J Neuroinflammation (2010) 1.68
Controlling neuropathic pain by adeno-associated virus driven production of the anti-inflammatory cytokine, interleukin-10. Mol Pain (2005) 1.66
Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia. Pharmacol Rev (2011) 1.66
The narcotic bowel syndrome: clinical features, pathophysiology, and management. Clin Gastroenterol Hepatol (2007) 1.60
IFN-gamma receptor signaling mediates spinal microglia activation driving neuropathic pain. Proc Natl Acad Sci U S A (2009) 1.57
Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology (2011) 1.50
An evolving cellular pathology occurs in dorsal root ganglia, peripheral nerve and spinal cord following intravenous administration of paclitaxel in the rat. Brain Res (2007) 1.49
Pathophysiology of fibromyalgia. Am J Med (2009) 1.47
Pain-related sensory innervation in monoiodoacetate-induced osteoarthritis in rat knees that gradually develops neuronal injury in addition to inflammatory pain. BMC Musculoskelet Disord (2011) 1.45
Possible role of spinal astrocytes in maintaining chronic pain sensitization: review of current evidence with focus on bFGF/JNK pathway. Neuron Glia Biol (2006) 1.41
Glia in pathological pain: a role for fractalkine. J Neuroimmunol (2008) 1.39
Therapeutic manipulation of peroxynitrite attenuates the development of opiate-induced antinociceptive tolerance in mice. J Clin Invest (2007) 1.37
Animal models of cancer pain. Comp Med (2008) 1.35
Counter-regulation of opioid analgesia by glial-derived bioactive sphingolipids. J Neurosci (2010) 1.34
Roles of reactive oxygen and nitrogen species in pain. Free Radic Biol Med (2011) 1.32
HSV-mediated expression of interleukin-4 in dorsal root ganglion neurons reduces neuropathic pain. Mol Pain (2006) 1.32
Do glial cells control pain? Neuron Glia Biol (2007) 1.30
A comparison of spinal Iba1 and GFAP expression in rodent models of acute and chronic pain. Brain Res (2008) 1.26
Central mechanisms in the maintenance of chronic widespread noninflammatory muscle pain. Curr Pain Headache Rep (2008) 1.26
Remote astrocytic and microglial activation modulates neuronal hyperexcitability and below-level neuropathic pain after spinal injury in rat. Neuroscience (2009) 1.26
Quantitating the subtleties of microglial morphology with fractal analysis. Front Cell Neurosci (2013) 1.26
Brief, low frequency stimulation of rat peripheral C-fibres evokes prolonged microglial-induced central sensitization in adults but not in neonates. Pain (2009) 1.24
Stereological and somatotopic analysis of the spinal microglial response to peripheral nerve injury. Brain Behav Immun (2006) 1.24
Microglia: a promising target for treating neuropathic and postoperative pain, and morphine tolerance. J Formos Med Assoc (2011) 1.24
NADPH oxidase 2-derived reactive oxygen species in spinal cord microglia contribute to peripheral nerve injury-induced neuropathic pain. Proc Natl Acad Sci U S A (2010) 1.22
Brain-derived neurotrophic factor from microglia: a molecular substrate for neuropathic pain. Neuron Glia Biol (2012) 1.21
Targeting the overproduction of peroxynitrite for the prevention and reversal of paclitaxel-induced neuropathic pain. J Neurosci (2012) 1.21
Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells. Brain Res (2008) 1.20
Central and peripheral sites of action for CB₂ receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats. Br J Pharmacol (2011) 1.20
Controlling murine and rat chronic pain through A3 adenosine receptor activation. FASEB J (2012) 1.20
The relationship of cancer symptom clusters to depressive affect in the initial phase of palliative radiation. J Pain Symptom Manage (2005) 1.19
Intrathecal polymer-based interleukin-10 gene delivery for neuropathic pain. Neuron Glia Biol (2006) 1.18
Plasticity in expression of the glutamate transporters GLT-1 and GLAST in spinal dorsal horn glial cells following partial sciatic nerve ligation. Mol Pain (2009) 1.17
Herpes vector-mediated gene transfer in the treatment of chronic pain. Mol Ther (2008) 1.17
Microglia and spinal cord synaptic plasticity in persistent pain. Neural Plast (2013) 1.17
Depression: a repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition? Neurosci Biobehav Rev (2010) 1.17
Biology and therapy of fibromyalgia: pain in fibromyalgia syndrome. Arthritis Res Ther (2006) 1.15
Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. Pain Res Treat (2012) 1.15
Crosstalk between spinal astrocytes and neurons in nerve injury-induced neuropathic pain. PLoS One (2009) 1.14
Impaired glial glutamate uptake induces extrasynaptic glutamate spillover in the spinal sensory synapses of neuropathic rats. J Neurophysiol (2010) 1.14
P2Y receptors and pain transmission. Purinergic Signal (2004) 1.12
Chemokine contribution to neuropathic pain: respective induction of CXCL1 and CXCR2 in spinal cord astrocytes and neurons. Pain (2013) 1.10
Differential involvement of trigeminal transition zone and laminated subnucleus caudalis in orofacial deep and cutaneous hyperalgesia: the effects of interleukin-10 and glial inhibitors. Mol Pain (2009) 1.08
Neuropathic pain in diabetes--evidence for a central mechanism. Nat Rev Neurol (2010) 1.08
Astrocytic CX43 hemichannels and gap junctions play a crucial role in development of chronic neuropathic pain following spinal cord injury. Glia (2012) 1.08
A brief comparison of the pathophysiology of inflammatory versus neuropathic pain. Curr Opin Anaesthesiol (2011) 1.08
Inhibition of Kinesin-5, a microtubule-based motor protein, as a strategy for enhancing regeneration of adult axons. Traffic (2011) 1.07
Neuronal CCL21 up-regulates microglia P2X4 expression and initiates neuropathic pain development. EMBO J (2011) 1.06
Differential expression of connexins in trigeminal ganglion neurons and satellite glial cells in response to chronic or acute joint inflammation. Neuron Glia Biol (2009) 1.05
Quantification of the rat spinal microglial response to peripheral nerve injury as revealed by immunohistochemical image analysis and flow cytometry. J Neurosci Methods (2007) 1.05
Down-regulation of Toll-like receptor 4 gene expression by short interfering RNA attenuates bone cancer pain in a rat model. Mol Pain (2010) 1.04
Tonabersat inhibits trigeminal ganglion neuronal-satellite glial cell signaling. Headache (2009) 1.04
Pain and Poppies: The Good, the Bad, and the Ugly of Opioid Analgesics. J Neurosci (2015) 1.03
Applications of gene therapy to the treatment of chronic pain. Curr Gene Ther (2008) 1.03
P2X4 receptors and neuropathic pain. Front Cell Neurosci (2013) 1.03
Purinoceptors in microglia and neuropathic pain. Pflugers Arch (2006) 1.02
Glia as a Link between Neuroinflammation and Neuropathic Pain. Immune Netw (2012) 1.02
Role of spinal cord glia in the central processing of peripheral pain perception. Neurogastroenterol Motil (2010) 1.01
Deficiency in complement C1q improves histological and functional locomotor outcome after spinal cord injury. J Neurosci (2008) 1.01
Mechanism of cancer pain. Mol Interv (2010) 1.00
Robust spinal neuroinflammation mediates mechanical allodynia in Walker 256 induced bone cancer rats. Mol Brain (2012) 0.99
Gabapentin reduces CX3CL1 signaling and blocks spinal microglial activation in monoarthritic rats. Mol Brain (2012) 0.99
Matrix metalloprotease regulation of neuropathic pain. Trends Pharmacol Sci (2009) 0.99
Intrathecal cannabilactone CB(2)R agonist, AM1710, controls pathological pain and restores basal cytokine levels. Pain (2012) 0.99
Inflammation and inflammatory control in interstitial cystitis/bladder pain syndrome: Associations with painful symptoms. Pain (2014) 0.98
Neuropathic pain and neuron-glia interactions in the spinal cord. J Anesth (2010) 0.98
Abnormal pain modulation in patients with spatially distributed chronic pain: fibromyalgia. Rheum Dis Clin North Am (2009) 0.98
Spinal leptin contributes to the pathogenesis of neuropathic pain in rodents. J Clin Invest (2009) 0.96
ATP receptors gate microglia signaling in neuropathic pain. Exp Neurol (2011) 0.96
Minocycline prevents impaired glial glutamate uptake in the spinal sensory synapses of neuropathic rats. Neuroscience (2010) 0.95
Expression of fractalkine and fractalkine receptor in urinary bladder after cyclophosphamide (CYP)-induced cystitis. Auton Neurosci (2006) 0.95
Inflaming the brain: CRPS a model disease to understand neuroimmune interactions in chronic pain. J Neuroimmune Pharmacol (2012) 0.95
Fractalkine mediates inflammatory pain through activation of satellite glial cells. Proc Natl Acad Sci U S A (2013) 0.94
Spinal astrocytic activation contributes to mechanical allodynia in a rat chemotherapy-induced neuropathic pain model. PLoS One (2013) 0.94
Carbon monoxide reduces neuropathic pain and spinal microglial activation by inhibiting nitric oxide synthesis in mice. PLoS One (2012) 0.94
Distinctive response of CNS glial cells in oro-facial pain associated with injury, infection and inflammation. Mol Pain (2010) 0.93
Gene therapy directed at the neuroimmune component of chronic pain with particular attention to the role of TNF alpha. Neurosci Lett (2008) 0.93
P2X4 purinoceptor signaling in chronic pain. Purinergic Signal (2012) 0.91
Ketorolac reduces spinal astrocytic activation and PAR1 expression associated with attenuation of pain after facet joint injury. J Neurotrauma (2013) 0.91
Influence of intrathecal delivery of bone marrow-derived mesenchymal stem cells on spinal inflammation and pain hypersensitivity in a rat model of peripheral nerve injury. J Neuroinflammation (2014) 0.90
Wogonin inhibits LPS-induced inflammatory responses in rat dorsal root ganglion neurons via inhibiting TLR4-MyD88-TAK1-mediated NF-κB and MAPK signaling pathway. Cell Mol Neurobiol (2014) 0.90
Is functional state of spinal microglia involved in the anti-allodynic and anti-hyperalgesic effects of electroacupuncture in rat model of monoarthritis? Neurobiol Dis (2007) 0.90
Antiallodynic Effect of Thalidomide and Morphine on Rat Spinal Nerve Ligation-induced Neuropathic Pain. Korean J Pain (2010) 0.89
Interleukin-1-induced interleukin-6 synthesis is mediated by the neutral sphingomyelinase/Src kinase pathway in neurones. Br J Pharmacol (2007) 0.89
Microglia: a newly discovered role in visceral hypersensitivity? Neuron Glia Biol (2006) 0.89
Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus. Nat Neurosci (2005) 5.61
Failure to escape traumatic shock. J Exp Psychol (1967) 3.11
Intrathecal HIV-1 envelope glycoprotein gp120 induces enhanced pain states mediated by spinal cord proinflammatory cytokines. J Neurosci (2001) 2.07
Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain (1995) 1.92
Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat. Pain (1997) 1.90
Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats. Eur J Neurosci (2004) 1.89
Immune regulation of central nervous system functions: from sickness responses to pathological pain. J Intern Med (2005) 1.86
Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120. Brain Res (2000) 1.83
Exposure to acute stress induces brain interleukin-1beta protein in the rat. J Neurosci (1998) 1.78
Characterization of cytokine-induced hyperalgesia. Brain Res (1994) 1.78
The immune system and memory consolidation: a role for the cytokine IL-1beta. Neurosci Biobehav Rev (2001) 1.74
Activation of serotonin-immunoreactive cells in the dorsal raphe nucleus in rats exposed to an uncontrollable stressor. Brain Res (1999) 1.73
Vagal immune-to-brain communication: a visceral chemosensory pathway. Auton Neurosci (2000) 1.71
Cytokine-to-brain communication: a review & analysis of alternative mechanisms. Life Sci (1995) 1.68
Brain-derived neurotrophic factor mRNA downregulation produced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist. Neuroscience (2003) 1.64
Selective effects of peripheral lipopolysaccharide administration on contextual and auditory-cue fear conditioning. Brain Behav Immun (1998) 1.62
The pain of being sick: implications of immune-to-brain communication for understanding pain. Annu Rev Psychol (2000) 1.60
Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication. Neurosci Lett (1995) 1.60
Controllable versus uncontrollable stressors bi-directionally modulate conditioned but not innate fear. Neuroscience (2007) 1.57
The role of the habenular complex in the elevation of dorsal raphe nucleus serotonin and the changes in the behavioral responses produced by uncontrollable stress. Brain Res (2001) 1.56
Opioid activation of toll-like receptor 4 contributes to drug reinforcement. J Neurosci (2012) 1.55
Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist: a possible mechanism for immune-to-brain communication. Brain Res Bull (1997) 1.55
Interleukin-1beta in immune cells of the abdominal vagus nerve: a link between the immune and nervous systems? J Neurosci (1999) 1.53
Implications of immune-to-brain communication for sickness and pain. Proc Natl Acad Sci U S A (1999) 1.52
Spinal cord glia: new players in pain. Pain (2001) 1.51
Learned helplessness and animal models of depression. Prog Neuropsychopharmacol Biol Psychiatry (1984) 1.47
Escapable and inescapable stress differentially alter extracellular levels of 5-HT in the basolateral amygdala of the rat. Brain Res (1998) 1.47
A method for increasing the viability of the external portion of lumbar catheters placed in the spinal subarachnoid space of rats. J Neurosci Methods (1999) 1.44
An initial investigation of spinal mechanisms underlying pain enhancement induced by fractalkine, a neuronally released chemokine. Eur J Neurosci (2005) 1.36
Microinjection of urocortin 2 into the dorsal raphe nucleus activates serotonergic neurons and increases extracellular serotonin in the basolateral amygdala. Neuroscience (2004) 1.35
Activation of the ventral medial prefrontal cortex during an uncontrollable stressor reproduces both the immediate and long-term protective effects of behavioral control. Neuroscience (2008) 1.33
Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1beta. Neuroscience (2010) 1.33
The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress. Endocrinology (1999) 1.32
Exposure to inescapable but not escapable shock increases extracellular levels of 5-HT in the dorsal raphe nucleus of the rat. Brain Res (1998) 1.32
Role of interleukin-1 beta in impairment of contextual fear conditioning caused by social isolation. Behav Brain Res (1999) 1.32
Mechanisms of tumor necrosis factor-alpha (TNF-alpha) hyperalgesia. Brain Res (1995) 1.25
Possible involvement of toll-like receptor 4/myeloid differentiation factor-2 activity of opioid inactive isomers causes spinal proinflammation and related behavioral consequences. Neuroscience (2010) 1.22
The contribution of the vagus nerve in interleukin-1beta-induced fever is dependent on dose. Am J Physiol Regul Integr Comp Physiol (2001) 1.19
The role of IL-1beta in stress-induced sensitization of proinflammatory cytokine and corticosterone responses. Neuroscience (2004) 1.16
Neurocircuitry of illness-induced hyperalgesia. Brain Res (1994) 1.16
Effects of vagotomy on serum endotoxin, cytokines, and corticosterone after intraperitoneal lipopolysaccharide. Am J Physiol Regul Integr Comp Physiol (2000) 1.15
Dynamic regulation of the proinflammatory cytokine, interleukin-1beta: molecular biology for non-molecular biologists. Life Sci (1999) 1.14
Coping and immunosuppression: inescapable but not escapable shock suppresses lymphocyte proliferation. Science (1983) 1.12
Stressor controllability and the pituitary-adrenal system. Behav Neurosci (1986) 1.11
Behavioral control over shock blocks behavioral and neurochemical effects of later social defeat. Neuroscience (2009) 1.09
Spinal upregulation of glutamate transporter GLT-1 by ceftriaxone: therapeutic efficacy in a range of experimental nervous system disorders. Neuroscience (2010) 1.09
Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activity. Neuroscience (2010) 1.07
Uncontrollable stress potentiates morphine's rewarding properties. Pharmacol Biochem Behav (1998) 1.07
A long-term increase in basal levels of corticosterone and a decrease in corticosteroid-binding globulin after acute stressor exposure. Endocrinology (1995) 1.07
Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy. Brain Behav Immun (2008) 1.05
Stressor controllability, social interaction, and benzodiazepine systems. Pharmacol Biochem Behav (1993) 1.04
Interleukin-1 induces c-Fos immunoreactivity in primary afferent neurons of the vagus nerve. Brain Res (1998) 1.03
Escapable and inescapable stress differentially and selectively alter extracellular levels of 5-HT in the ventral hippocampus and dorsal periaqueductal gray of the rat. Brain Res (1998) 1.02
Thermogenic and corticosterone responses to intravenous cytokines (IL-1beta and TNF-alpha) are attenuated by subdiaphragmatic vagotomy. J Neuroimmunol (1998) 1.02
Evidence for a role of heat shock protein-90 in toll like receptor 4 mediated pain enhancement in rats. Neuroscience (2009) 1.02
The effect of stressor controllability on stress-induced neuropeptide mRNA expression within the paraventricular nucleus of the hypothalamus. J Neuroendocrinol (1999) 1.01
Prostaglandins are necessary and sufficient to induce contextual fear learning impairments after interleukin-1 beta injections into the dorsal hippocampus. Neuroscience (2007) 1.00
Evidence that brief stress may induce the acute phase response in rats. Am J Physiol (1997) 1.00
Conditioned inhibition and the UCS-CS interval. Anim Learn Behav (1976) 0.99
Alleviation of learned helplessness in the dog. J Abnorm Psychol (1968) 0.99
Comparison of the effects of nucleus tractus solitarius and ventral medial medulla lesions on illness-induced and subcutaneous formalin-induced hyperalgesias. Brain Res (1997) 0.97
Cholecystokinin antianalgesia: safety cues abolish morphine analgesia. Science (1992) 0.96
Acute stressor exposure both suppresses acquired immunity and potentiates innate immunity. Am J Physiol (1998) 0.96
Bacterial endotoxin induces fos immunoreactivity in primary afferent neurons of the vagus nerve. Neuroimmunomodulation (1998) 0.96
Expression of fibroblast growth factor-2 and brain-derived neurotrophic factor mRNA in the medial prefrontal cortex and hippocampus after uncontrollable or controllable stress. Neuroscience (2006) 0.95
Timecourse and corticosterone sensitivity of the brain, pituitary, and serum interleukin-1beta protein response to acute stress. Brain Res (2000) 0.95
Exercise does not modify spatial memory, brain autoimmunity, or antibody response in aged F-344 rats. Neurobiol Aging (1991) 0.95
Effects of vagotomy on lipopolysaccharide-induced brain interleukin-1beta protein in rats. Auton Neurosci (2000) 0.93
Interleukin-1 beta induced corticosterone elevation and hypothalamic NE depletion is vagally mediated. Brain Res Bull (1995) 0.92
Subdiaphragmatic vagotomy does not block intraperitoneal lipopolysaccharide-induced fever. Auton Neurosci (2000) 0.91
Stress potentiation of morphine-induced dopamine efflux in the nucleus accumbens shell is dependent upon stressor uncontrollability and is mediated by the dorsal raphe nucleus. Neuroscience (2004) 0.91
Subcutaneous formalin produces centrifugal hyperalgesia at a non-injected site via the NMDA-nitric oxide cascade. Brain Res (1994) 0.90
5-hydroxytryptamine 2C receptors in the dorsal striatum mediate stress-induced interference with negatively reinforced instrumental escape behavior. Neuroscience (2011) 0.89
Blockade of alpha1 adrenoreceptors in the dorsal raphe nucleus prevents enhanced conditioned fear and impaired escape performance following uncontrollable stressor exposure in rats. Behav Brain Res (2002) 0.89
Impaired escape performance and enhanced conditioned fear in rats following exposure to an uncontrollable stressor are mediated by glutamate and nitric oxide in the dorsal raphe nucleus. Behav Brain Res (2000) 0.89
Circulating cytokines and endotoxin are not necessary for the activation of the sickness or corticosterone response produced by peripheral E. coli challenge. J Appl Physiol (1985) (2003) 0.88
Coping and the stress-induced potentiation of stimulant stereotypy in the rat. Science (1983) 0.87
Long-term analgesic effects of inescapable shock and learned helplessness. Science (1979) 0.86
Effects of task-irrelevant cues and reinforcement delay on choice-escape learning following inescapable shock: evidence for a deficit in selective attention. J Exp Psychol Anim Behav Process (1984) 0.86
Illness-induced hyperalgesia is mediated by spinal neuropeptides and excitatory amino acids. Brain Res (1994) 0.86
Stress, learned helplessness, and brain interleukin-1 beta. Adv Exp Med Biol (1999) 0.86
Long-term control of neuropathic pain in a non-viral gene therapy paradigm. Gene Ther (2009) 0.85
Kappa opiate receptors mediate tail-shock induced antinociception at spinal levels. Brain Res (1992) 0.85
Opiate antagonists and long-term analgesic reaction induced by inescapable shock in rats. J Comp Physiol Psychol (1980) 0.85
Endogenous glucocorticoids play a positive regulatory role in the anti-keyhole limpet hemocyanin in vivo antibody response. J Immunol (2001) 0.85
Long-term stress-induced analgesia and activation of the opiate system. Science (1981) 0.85
The estrous cycle and estrogen modulate stress-induced analgesia. Behav Neurosci (1988) 0.85
Acute and conditioned hyperalgesic responses to illness. Pain (1994) 0.85
The opioid/nonopioid nature of stress-induced analgesia and learned helplessness. J Exp Psychol Anim Behav Process (1983) 0.85
Inescapable shock induces resistance to the effects of dexamethasone. Psychoneuroendocrinology (2003) 0.85
Sciatic inflammatory neuritis (SIN): behavioral allodynia is paralleled by peri-sciatic proinflammatory cytokine and superoxide production. J Peripher Nerv Syst (2001) 0.84
Neurocircuitry of conditioned inhibition of analgesia: effects of amygdala, dorsal raphe, ventral medullary, and spinal cord lesions on antianalgesia in the rat. Behav Neurosci (1998) 0.84
Blockade of cytokine induced conditioned taste aversion by subdiaphragmatic vagotomy: further evidence for vagal mediation of immune-brain communication. Neurosci Lett (1995) 0.84